Use of Disease-Monitoring Tests Often Extreme in Breast Cancer

This article originally appeared here.
Share this content:
Use of Disease-Monitoring Tests Often Extreme in Breast Cancer
Use of Disease-Monitoring Tests Often Extreme in Breast Cancer

THURSDAY, May 12, 2016 (HealthDay News) -- More than one in three women with metastatic breast cancer (MBC) are extreme users of disease-monitoring tests, with higher total health care costs seen in association with extreme use, according to a study published online May 9 in the Journal of Clinical Oncology.

Melissa K. Accordino, M.D., from the Columbia University Medical Center in New York City, and colleagues identified women with MBC diagnosed from 2002 to 2011 who underwent disease monitoring. The authors recorded the billing dates of serum tumor marker (STM) and imaging tests. Extreme use was defined as more than 12 STM and/or more than four radiographic imaging tests in a 12-month period.

The researchers identified 2,460 eligible patients, of whom 37.6 percent were extreme users of disease-monitoring tests. Hormone receptor-negative MBC, history of positron emission tomography scan, and more frequent oncology office visits were associated with extreme use (odds ratios, 1.63, 2.92, and 3.14, respectively). Extreme users had medical costs that were 59.2 percent higher per year. At the end of life, extreme users were more likely to use emergency department and hospice services.

"Despite an unknown clinical benefit, approximately one-third of elderly women with MBC were extreme users of disease-monitoring tests," the authors write. "Efforts to understand the optimal frequency of monitoring are needed to inform clinical practice."

One author disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Seeks to Increase Number of Generic Drugs on Market

FDA Seeks to Increase Number of Generic Drugs ...

Agency will now give priority reviews to new generic drugs until there are at least three available

PPIs Not Found to Raise Risk of Alzheimer's Disease

PPIs Not Found to Raise Risk of Alzheimer's ...

New research debunks other studies suggesting that PPIs cause mental decline

Aspirin Effective in Pregnancies at High Risk for Preeclampsia

Aspirin Effective in Pregnancies at High Risk for ...

Odds of preeclampsia drop for high-risk women who take 150 mg of aspirin daily, researchers find

is free, fast, and customized just for you!

Already a member?

Sign In Now »